BACE1 and Alzheimer disease: Verubecestat, for example, inhibits BACE1 (β-amyloid precursor protein lyase 1) and reduces Aβ protein in the cerebrospinal fluid of healthy people and AD by about 60%; however, verubecestat does not improve cognitive function at any dose [5].